Current Issue

Original research

• Prediction modelling the impact of onset to treatment time on the modified Rankin Scale score at 90 days for patients with acute ischaemic stroke (16 August, 2022)

  Nicklas Ennab Vogel, Turgut Tatlisumak, Per Wester, Johan Lyth, Lars-Åke Levin
• Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid (10 August, 2022)

  Kensaku Kasuga, Masataka Kikuchi, Tamao Tsukie, Kazushi Suzuki, Ryoko Ihara, Atsushi Iwata, Norikazu Hara, Akinori Miyashita, Ryozo Kuwano, Takeshi Iwatsubo, Takeshi Ikeuchi
• Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment (27 July, 2022)

  Linn Persson Berg, Marcus Eriksson, Sonia Longhi, Ingrid Kockum, Clemens Warnke, Elisabeth Thomsson, Malin Bäckström, Tomas Olsson, Anna Fogdell-Hahn, Tomas Bergström
• Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design (15 July, 2022)

  Jorge E Quintero, John T Slevin, Julie A Gurwell, Christopher J McLouth, Riham El Khouli, Monica J Chau, Zain Guduru, Greg A Gerhardt, Craig G van Horne
• Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study (12 July, 2022)

  Arina A Tamborska, Bhagteshwar Singh, Sonja E Leonhard, Eva Maria Hodel, Julia Stowe, Taylor Watson-Fargie, Peter M Fernandes, Andreas C Themistocleous, Jacob Roelofs, Kathryn Brennan, Caroline Morrice, Benedict D Michael, Bart C Jacobs, Helen McDonald, Tom Solomon
• Large vessel occlusion prediction scales provide high negative but low positive predictive values in prehospital suspected stroke patients (11 July, 2022)

  Kevin J Keenan, Wade S Smith, Sara B Cole, Christine Martin, J Claude Hemphill, Debbie Y Madhok
• Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data (4 July, 2022)

  Todd A Hardy, John Parratt, Heidi Beadnall, Stefan Blum, Richard Macdonell, Roy G Beran, Neil Shuey, Andrew Lee, William Carroll, Cameron Shaw, Richard Worrell, Jana Moody, Mamdouh Sedhom, Michael Barnett, Steve Vucic